[en] Streptococcus agalactiae (Group B Streptococcus, GBS) is a commensal of the digestive and genitourinary tracts of humans that emerged as the leading cause of bacterial neonatal infections in Europe and North America during the 1960s. Due to the lack of epidemiological and genomic data, the reasons for this emergence are unknown. Here we show by com- parative genome analysis and phylogenetic reconstruction of 229 isolates that the rise of human GBS infections corresponds to the selection and worldwide dissemination of only a few clones. The parallel expansion of the clones is preceded by the insertion of integrative and conjugative elements conferring tetracycline resistance (TcR). Thus, we propose that the use of tetracycline from 1948 onwards led in humans to the complete replacement of a diverse GBS population by only few TcR clones particularly well adapted to their host, causing the observed emergence of GBS diseases in neonates.
Research Center/Unit :
Institut Pasteur Genopole France
Disciplines :
Microbiology
Author, co-author :
Da Cunha, Violette; Institut Pasteur France > Unité de Biologie des Bacteries Pathogènes à Gram-positif
Davies, MR; he Wellcome Trust Sanger Institute, Hinxton, Cambridge CB10 15A, UK
Douarre, Pierre-Emmanuel; Institut Pasteur France > Unité de Biologie des Bacteries Pathogènes à Gram-positif
MELIN, Pierrette ; Centre Hospitalier Universitaire de Liège - CHU > Microbiologie médicale
Glaser, Philippe; Institut Pasteur France
Language :
English
Title :
Streptococcus agalactiae clones infecting humans were selected and fixed through the extensive use of tetracycline
Publication date :
04 August 2014
Journal title :
Nature Communications
eISSN :
2041-1723
Publisher :
Nature Pub.lishing Group, London, United Kingdom
Peer reviewed :
Peer Reviewed verified by ORBi
European Projects :
FP7 - 200481 - DEVANI - Design of a vaccine to immunize neonates against GBS infections through a durable maternal immune response
Edwards, M. S. & Baker, C. J. Group B streptococcal infections. In: Infectious Diseases of the Fetus and Newborn Infant (eds Klein, J. O. & Remington, J. S.) (Saunders, 2005).
Edmond, K. M. et al. Group B streptococcal disease in infants aged younger than 3 months: systematic review and meta-analysis. Lancet 379, 547-556 (2012).
Eickhoff, T. C., Klein, J. O., Daly, A. K., Ingall, D. & Finland, M. Neonatal sepsis and other infections due to group B beta-hemolytic streptococci. N. Engl. J. Med. 271, 1221-1228 (1964).
Kexel, G. & Schoenbohm, S. Streptococcus agalactiae as the causative agent in infantile meningitis. Dtsch. Med. Wochenschr. 90, 258-261 (1965).
Jones, N. et al. Multilocus sequence typing system for group B streptococcus. J. Clin. Microbiol. 41, 2530-2536 (2003). (Pubitemid 36712464)
Tazi, A. et al. The surface protein HvgA mediates group B streptococcus hypervirulence and meningeal tropism in neonates. J. Exp. Med. 207, 2313-2322 (2010).
Brochet, M., Couve, E., Bercion, R., Sire, J. M. & Glaser, P. Population structure of human isolates of Streptococcus agalactiae from Dakar and Bangui. J. Clin. Microbiol. 47, 800-803 (2009).
Nocard, M. & Mollereau, H. Sur unemammite contagieuse des vaches laitieres. Ann. Inst. Pasteur 1, 109-126 (1887).
Sorensen, U. B., Poulsen, K., Ghezzo, C., Margarit, I. & Kilian, M. Emergence and global dissemination of host-specific Streptococcus agalactiae clones. MBio 1 pii e00178-10 (2010).
Brochet, M. et al. Shaping a bacterial genome by large chromosomal replacements, the evolutionary history of Streptococcus agalactiae. Proc. Natl Acad. Sci. USA 105, 15961-15966 (2008).
Lindahl, G., Stalhammar-Carlemalm, M. & Areschoug, T. Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin. Microbiol. Rev. 18, 102-127 (2005). (Pubitemid 40170663)
Drummond, A. J., Suchard, M. A., Xie, D. & Rambaut, A. Bayesian phylogenetics with BEAUti and the BEAST 1.7. Mol. Biol. Evol. 29, 1969-1973 (2012).
He, M. et al. Emergence and global spread of epidemic healthcare-associated Clostridium difficile. Nat. Genet. 45, 109-113 (2012).
Croucher, N. J. et al. Rapid pneumococcal evolution in response to clinical interventions. Science 331, 430-434 (2011).
Usein, C. R. et al. Molecular characterization of adult-colonizing Streptococcus agalactiae from an area-based surveillance study in Romania. Eur. J. Clin. Microbiol. Infect. Dis. 31, 2301-2310 (2012).
Boswihi, S. S., Udo, E. E. & Al-Sweih, N. Serotypes and antibiotic resistance in Group B streptococcus isolated from patients at the Maternity Hospital, Kuwait. J. Med. Microbiol. 61, 126-131 (2012).
Hraoui, M., Boutiba-Ben Boubaker, I., Rachdi, M., Slim, A. & Ben Redjeb, S. Macrolide and tetracycline resistance in clinical strains of Streptococcus agalactiae isolated in Tunisia. J. Med. Microbiol. 61, 1109-1113 (2012).
Rato, M. G. et al. Antimicrobial resistance and molecular epidemiology of streptococci from bovine mastitis. Vet. Microbiol. 161, 286-294 (2013).
Haenni, M. et al. Diversity and mobility of integrative and conjugative elements in bovine isolates of Streptococcus agalactiae, S. dysgalactiae subsp. dysgalactiae, and S. uberis. Appl. Environ. Microbiol. 76, 7957-7965 (2010).
Kalmus, P., Aasmae, B., Karssin, A., Orro, T. & Kask, K. Udder pathogens and their resistance to antimicrobial agents in dairy cows in Estonia. Acta. Vet. Scand. 53, 4 (2011).
Dogan, B., Schukken, Y. H., Santisteban, C. & Boor, K. J. Distribution of serotypes and antimicrobial resistance genes among Streptococcus agalactiae isolates from bovine and human hosts. J. Clin. Microbiol. 43, 5899-5906 (2005). (Pubitemid 43100635)
Baquero, F., Tedim, A. P. & Coque, T. M. Antibiotic resistance shaping multi-level population biology of bacteria. Front. Microbiol. 4, 15 (2013).
Verani, J. R., McGee, L. & Schrag, S. J. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010. MMWR Recomm. Rep. 59, 1-36 (2010).
De Francesco, M. A., Caracciolo, S., Gargiulo, F. & Manca, N. Phenotypes, genotypes, serotypes and molecular epidemiology of erythromycin-resistant Streptococcus agalactiae in Italy. Eur. J. Clin. Microbiol. Infect. Dis. 31, 1741-1747 (2012).
McDougal, L. K. et al. Detection of Tn917-like sequences within a Tn916-like conjugative transposon (Tn3872) in erythromycin-resistant isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42, 2312-2318 (1998). (Pubitemid 28420370)
Puopolo, K. M., Klinzing, D. C., Lin, M. P., Yesucevitz, D. L. & Cieslewicz, M. J. A composite transposon associated with erythromycin and clindamycin resistance in group B streptococcus. J. Med. Microbiol. 56, 947-955 (2007). (Pubitemid 47047489)
Patterson, M. J. & El Batool Hafeez, A. Group B streptococci in human disease. Bacteriol. Rev. 40, 774-792 (1976).
Chopra, I. & Roberts, M. Tetracycline antibiotics: mode of action, applications, molecular biology, and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65, 232-260 (2001). (Pubitemid 32538179)
Wyres, K. L. et al. Evidence of antimicrobial resistance-conferring genetic elements among pneumococci isolated prior to 1974. BMC Genomics 14, 500 (2013).
Thaker, M., Spanogiannopoulos, P. & Wright, G. D. The tetracycline resistome. Cell. Mol. Life. Sci. 67, 419-431 (2010).
Roberts, A. P. & Mullany, P. Tn916-like genetic elements: a diverse group of modular mobile elements conferring antibiotic resistance. FEMS Microbiol. Rev. 35, 856-871 (2011).
Celli, J. & Trieu-Cuot, P. Circularization of Tn916 is required for expression of the transposon-encoded transfer functions: characterization of long tetracycline-inducible transcripts reading through the attachment site. Mol. Microbiol. 28, 103-117 (1998). (Pubitemid 28160117)
Hu, Y. et al. Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat. Commun. 4, 2151 (2013).
Arias, C. A. & Murray, B. E. The rise of the Enterococcus: beyond vancomycin resistance. Nat. Rev. Microbiol. 10, 266-278 (2012).
Davies, J. & Davies, D. Origins and evolution of antibiotic resistance. Microbiol. Mol. Biol. Rev. 74, 417-433 (2010).
Tenover, F. C. & Goering, R. V. Methicillin-resistant Staphylococcus aureus strain USA300: origin and epidemiology. J. Antimicrob. Chemother. 64, 441-446 (2009).
Planet, P. J. et al. Emergence of the epidemic methicillin-resistant Staphylococcus aureus strain USA300 coincides with horizontal transfer of the arginine catabolic mobile element and speG-mediated adaptations for survival on skin. MBio 4, e00889-13 (2013).
Willems, R. J. et al. Restricted gene flow among hospital subpopulations of Enterococcus faecium. MBio 3, e00151-00112 (2012).
Lebreton, F. et al. Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strains. MBio 4 pii e00534-13 (2013).
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 25, 1754-1760 (2009).
Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
Tettelin, H. et al. Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial 'pan-genome'. Proc. Natl Acad. Sci. USA 102, 13950-13955 (2005). (Pubitemid 41377684)
Glaser, P. et al. Genome sequence of Streptococcus agalactiae, a pathogen causing invasive neonatal disease. Mol. Microbiol. 45, 1499-1513 (2002). (Pubitemid 35231970)
Darling, A. C., Mau, B., Blattner, F. R. & Perna, N. T. Mauve: multiple alignment of conserved genomic sequence with rearrangements. Genome Res. 14, 1394-1403 (2004). (Pubitemid 39029237)
Tettelin, H. et al. Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc. Natl Acad. Sci. USA 99, 12391-12396 (2002).
Aziz, R. K. et al. The RAST Server: rapid annotations using subsystems technology. BMC Genomics 9, 75 (2008).
Zerbino, D. R. & Birney, E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res. 18, 821-829 (2008). (Pubitemid 351645072)
Rosinski-Chupin, I. et al. Reductive evolution in Streptococcus agalactiae and the emergence of a host adapted lineage. BMC Genomics 14, 252 (2013).
Lechat, P., Souche, E. & Moszer, I. SynTView-an interactive multi-view genome browser for next-generation comparative microorganism genomics. BMC Bioinformatics 14, 277 (2013).
Tamura, K. et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28, 2731-2739 (2011).
Drummond, A. J. & Rambaut, A. BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol. Biol. 7, 214 (2007).
Baele, G. et al. Improving the accuracy of demographic and molecular clock model comparison while accommodating phylogenetic uncertainty. Mol. Biol. Evol. 29, 2157-2167 (2012).
Baele, G. & Lemey, P. Bayesian evolutionary model testing in the phylogenomics era: matching model complexity with computational efficiency. Bioinformatics 29, 1970-1979 (2013).
Drummond, A. J., Ho, S. Y., Phillips, M. J. & Rambaut, A. Relaxed phylogenetics and dating with confidence. PLoS Biol. 4, e88 (2006).
Luan, S. L. et al. Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching. J. Clin. Microbiol. 43, 3727-3733 (2005).
Manning, S. D. et al. Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada. J. Clin. Microbiol. 47, 1143-1148 (2009).
Bohnsack, J. F. et al. Population structure of invasive and colonizing strains of Streptococcus agalactiae from neonates of six U.S. Academic Centers from 1995 to 1999. J. Clin. Microbiol. 46, 1285-1291 (2008). (Pubitemid 351563569)
Sadowy, E., Matynia, B. & Hryniewicz, W. Population structure, virulence factors and resistance determinants of invasive, non-invasive and colonizing Streptococcus agalactiae in Poland. J. Antimicrob. Chemother. 65, 1907-1914 (2010).
Huber, C. A., McOdimba, F., Pflueger, V., Daubenberger, C. A. & Revathi, G. Characterization of invasive and colonizing isolates of Streptococcus agalactiae in East African adults. J. Clin. Microbiol. 49, 3652-3655 (2011).